Antagonizing leptin: Current status and future directions

Biological Chemistry

Volumn 395, Issue 5, 2014, Pages 499-514

  Zabeau, Lennart ^a   Peelman, Frank ^a   Tavernier, Jan ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Antagonism; Autoimmunity; Leptin

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR ANTIBODY; NANOBODY; NEUROPEPTIDE Y; NEUTRALIZING ANTIBODY; RECOMBINANT LEPTIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BODY WEIGHT; CD4+ T LYMPHOCYTE; CRYSTALLOGRAPHY; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; MUTAGENESIS; NEOPLASM; NONHUMAN; OBESITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY; ADIPOCYTE; ANTAGONISTS AND INHIBITORS; IMMUNOLOGY; METABOLISM;

ADIPOCYTES; HUMANS; LEPTIN; OBESITY; SIGNAL TRANSDUCTION;

EID: 84900866393     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0283     Document Type: Review

References (173)

1. Adriani, M., Garbi, C., Amodio, G., Russo, I., Giovannini, M., Amorosi, S., Matrecano, E., Cosentini, E., Candotti, F., and Pignata, C. (2006). Functional interaction of common-γ-chain and growth hormone receptor signaling apparatus. J. Immunol. 177, 6889-6895. (Pubitemid 44715054)
2. Andersson, U., Filipsson, K., Abbott, C.R., Woods, A., Smith, K., Bloom, S.R., Carling, D., and Small, C.J. (2004). AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279, 12005-12008. (Pubitemid 38445761)
3. Artwohl, M., Roden, M., Hölzenbein, T., Freudenthaler, A., Waldhäusl, W., and Baumgartner-Parzer, S.M. (2002). Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int. J. Obes. Relat. Metab. Disord. 26, 577-580. (Pubitemid 34407273)
4. Attig, L., Solomon, G., Ferezou, J., Abdennebi-Najar, L., Taouis, M., Gertler, A., and Djiane, J. (2008). Early postnatal leptin blockage leads to a long-term leptin resistance and susceptibility to diet-induced obesity in rats. Int. J. Obes. (Lond). 32, 1153-1160.
5. Attig, L., Larcher, T., Gertler, A., Abdennebi-Najar, L., and Djiane, J. (2011). Postnatal leptin is necessary for maturation of numerous organs in newborn rats. Organogenesis 7, 88-94.
6. Bado, A., Levasseur, S., Attoub, S., Kermorgant, S., Laigneau, J.P., Bortoluzzi, M.N., Moizo, L., Lehy, T., Guerre-Millo, M., Le Marchand-Brustel, Y., et al. (1998). The stomach is a source of leptin. Nature 394, 790-793. (Pubitemid 28391644)
7. Bahrenberg, G., Behrmann, I., Barthel, A., Hekerman, P., Heinrich, P.C., Joost, H.-G., and Becker, W. (2002). Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/ signal transducer and activator of transcription activation by receptor heterodimers. Mol. Endocrinol. 16, 859-872. (Pubitemid 34297753)
8. Banks, A.S., Davis, S.M., Bates, S.H., and Myers, M.G. (2000). Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275, 14563-14572. (Pubitemid 30339746)
9. Barness, L.A., Opitz, J.M., and Gilbert-Barness, E. (2007). Obesity: genetic, molecular, and environmental aspects. Am. J. Med. Genet. A 143A, 3016-3034. (Pubitemid 350274816)
10. Bates, S.H., Stearns, W.H., Dundon, T.A., Schubert, M., Tso, A.W., Wang, Y., Banks, A.S., Lavery, H.J., Haq, A.K., Maratos-Flier, E., et al. (2003). STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421, 856-859. (Pubitemid 36254146)
11. Baumann, H., Morella, K.K., White, D.W., Dembski, M., Bailon, P.S., Kim, H., Lai, C.F., and Tartaglia, L.A. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93, 8374-8378. (Pubitemid 26269565)
12. Bennett, B.D., Solar, G.P., Yuan, J.Q., Mathias, J., Thomas, G.R., and Matthews, W. (1996). A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6, 1170-1180.
13. Bing, C., Taylor, S., Tisdale, M.J., and Williams, G. (2001). Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J. Neurochem. 79, 1004-1012. (Pubitemid 33117079)
14. Bjørbaek, C., Uotani, S., da Silva, B., and Flier, J.S. (1997). Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272, 32686-32695.
15. Bjorbaek, C., Elmquist, J.K., Michl, P., Ahima, R.S., van Bueren, A., McCall, A.L., and Flier, J.S. (1998). Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology 139, 3485-3491. (Pubitemid 28512305)
16. Bjørbaek, C., Buchholz, R.M., Davis, S.M., Bates, S.H., Pierroz, D.D., Gu, H., Neel, B.G., Myers, M.G., and Flier, J.S. (2001). Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276, 4747-4755.
17. Brines, M. (2010). The therapeutic potential of erythropoiesisstimulating agents for tissue protection: a tale of two receptors. Blood Purif. 29, 86-92.
18. Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.W., Smart, J., Su-Rick, C.J., et al. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. USA 101, 14907-14912. (Pubitemid 39410773)
19. Brines, M., Patel, N.S., Villa, P., Brines, C., Mennini, T., De Paola, M., Erbayraktar, Z., Erbayraktar, S., Sepodes, B., Thiemermann, C., et al. (2008). Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. USA 105, 10925-10930.
20. Burks, D.J., Font de Mora, J., Schubert, M., Withers, D.J., Myers, M.G., Towery, H.H., Altamuro, S.L., Flint, C.L., and White, M.F. (2000). IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377-382.
21. Busso, N., So, A., Chobaz-Peclat, V., Morard, C., Martinez-soria, E., Talabot-ayer, D., and Gabay, C. (2002). Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 168, 875-882. (Pubitemid 34049591)
22. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B., and Vasson, M.P. (2001). Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukoc. Biol. 69, 414-418
23. Caldefie-Chezet, F., Poulin, A., and Vasson, M.P. (2003). Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 37, 809-814.
24. Calle, E.E. (2007). Obesity and cancer. Br. Med. J. 335, 1107-1108. (Pubitemid 350247271)
25. Campión, J., Milagro, F., and Martínez, J.A. (2010). Epigenetics and obesity. Prog. Mol. Biol. Transl. Sci. 94, 291-347.
26. Carpenter, L.R., Farruggella, T.J., Symes, A., Karow, M.L., Yancopoulos, G.D., and Stahl, N. (1998). Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor. Proc. Natl. Acad. Sci. USA 95, 6061-6066. (Pubitemid 28248964)
27. Carpenter, B., Hemsworth, G.R., Wu, Z., Maamra, M., Strasburger, C.J., Ross, R.J., and Artymiuk, P.J. (2012). Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody. Structure 20, 487-497.
28. Catalano, S., Marsico, S., Giordano, C., Mauro, L., Rizza, P., Panno, M.L., and Andó S. (2003). Leptin enhances, via AP- 1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278, 28668-28676. (Pubitemid 36935773)
29. Chapnik, N., Solomon, G., Genzer, Y., Miskin, R., Gertler, A., and Froy, O. (2013). A superactive leptin antagonist alters metabolism and locomotion in high-leptin mice. J. Endocrinol. 217, 283-290.
30. Chehab, F.F., Lim, M.E., and Lu, R. (1996). Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12, 318-320. (Pubitemid 26080094)
31. Cheung, W.W., Ding, W., Gunta, S.S., Gu, Y., Tabakman, R., Klapper, L.N., Gertler, A., and Mak, R.H. (2014). A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice. J. Am. Soc. Nephrol. 25, 119-128.
32. Cheunsuang, O. and Morris, R. (2005). Astrocytes in the arcuate nucleus and median eminence that take up a fluorescent dye from the circulation express leptin receptors and neuropeptide Y Y1 receptors. Glia 52, 228-233. (Pubitemid 43076153)
33. Choi, J.-H., Choi, K.-C., Auersperg, N., and Leung, P.C. (2004). Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 89, 5508-5516. (Pubitemid 39518434)
34. Cirillo, D., Rachiglio, A.M., la Montagna, R., Giordano, A., and Normanno, N. (2008). Leptin signaling in breast cancer: an overview. J. Cell. Biochem. 105, 956-964.
35. Claycombe, K., King, L.E., and Fraker, P.J. (2008). A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc. Natl. Acad. Sci. USA 105, 2017-2021.
36. Coleman, D.L. (1973). Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9, 294-298.
37. Coleman, D.L. (2010). A historical perspective on leptin. Nat. Med. 16, 1097-1099.
38. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J., Bauer, T.L., et al. (1996). Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295. (Pubitemid 26033933)
39. Couturier, C. and Jockers, R. (2003). Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J. Biol. Chem. 278, 26604-26611. (Pubitemid 36876805)
40. Cui, H., Cai, F., and Belsham, D.D. (2006). Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/ 2, and p38 through c-Fos and ATF1. FASEB J. 20, 2654-2656.
41. De Rosa, V., Procaccini, C., La Cava, A., Chieffi, P., Nicoletti, G.F., Fontana, S., Zappacosta, S., and Matarese, G. (2006). Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J. Clin. Invest. 116, 447-455. (Pubitemid 43228362)
42. De Rosa, V., Procaccini, C., Call G., Pirozzi, G., Fontana, S., Zappacosta, S., La Cava, A., Matarese, G., and Cali, G. (2007). A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255. (Pubitemid 46329441)
43. Duan, C., Li, M., and Rui, L. (2004). SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J. Biol. Chem. 279, 43684-43691. (Pubitemid 39390672)
44. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Vinson, C., Rueger, J.M., and Karsenty, G. (2000). Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207. (Pubitemid 30064908)
45. Elias, C.F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R.S., Bjorbaek, C., Flier, J.S., Saper, C.B., and Elmquist, J.K. (1999). Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775-786. (Pubitemid 29411566)
46. Elinav, E., Ali, M., Bruck, R., Brazowski, E., Phillips, A., Shapira, Y., Katz, M., Solomon, G., Halpern, Z., and Gertler, A. (2009a). Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. Hepatology 49, 278-286.
47. Elinav, E., Niv-Spector, L., Katz, M., Price, T.O., Ali, M., Yacobovitz, M., Solomon, G., Reicher, S., Lynch, J.L., Halpern, Z., et al. (2009b). Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology 150, 3083-3091.
48. Faggioni, R., Jones-Carson, J., Reed, D.A., Dinarello, C.A., Feingold, K.R., Grunfeld, C., and Fantuzzi, G. (2000). Leptindeficient (ob/ob). Mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc. Natl. Acad. Sci. USA 97, 2367-2372. (Pubitemid 30134075)
49. Faouzi, M., Leshan, R., Bjornholm, M., Hennessey, T., Jones, J., and Munzberg, H. (2007). Differential accessibility of circulating leptin to individual hypothalamic sites. Endocrinology 148, 5414-5423. (Pubitemid 350012627)
50. Farooqi, I.S., Matarese, G., Lord, G.M., Keogh, J.M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S.A., Perna, F., Fontana, S., et al. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103. (Pubitemid 35215890)
51. Fei, H., Okano, H.J., Li, C., Lee, G.H., Zhao, C., Darnell, R., and Friedman, J.M. (1997). Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA 94, 7001-7005. (Pubitemid 27281980)
52. Ferla, R., Bonomi, M., Otvos, L., and Surmacz, E. (2011). Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects. BMC Cancer 11, 303.
53. Fong, T.M., Huang, R.R., Tota, M.R., Mao, C., Smith, T., Varnerin, J., Karpitskiy V.V., Krause, J.E., and Van der Ploeg, L.H. (1998). Localization of leptin binding domain in the leptin receptor. Mol. Pharmacol. 53, 234-240. (Pubitemid 28099733)
54. Frankenberry, K.A., Skinner, H., Somasundar, P., McFadden, D.W., and Vona-Davis, L.C. (2006). Leptin receptor expression and cell signaling in breast cancer. Int. J. Oncol. 28, 985-993.
55. Frederich, R.C., Lollmann, B., Hamann, A., Napolitano-Rosen, A., Kahn, B.B., Lowell, B.B., and Flier, J.S. (1995). Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96, 1658-1663.
56. Friedman, J.M. and Halaas, J.L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763-770. (Pubitemid 28485436)
57. Gainsford, T., Willson, T.A., Metcalf, D., Handman, E., McFarlane, C., Ng, A., Nicola, N.A., Alexander, W.S., and Hilton, D.J. (1996). Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA 93, 14564-14568. (Pubitemid 26419007)
58. Garofalo, C. and Surmacz, E. (2006). Leptin and cancer. J. Cell. Physiol. 207, 12-22.
59. Ge, H., Huang, L., Pourbahrami, T., and Li, C. (2002). Generation of soluble leptin receptor by ectodomain shedding of membranespanning receptors in vitro and in vivo. J. Biol. Chem. 277, 45898-45903. (Pubitemid 35417571)
60. Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R., Heim, M.H., and Skoda, R.C. (1996). Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93, 6231-6235. (Pubitemid 26230287)
61. Gogas, H., Trakatelli, M., Dessypris, N., Terzidis, A., Katsambas, A., Chrousos, G.P., and Petridou, E.T. (2008). Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann. Oncol. 19, 384-389. (Pubitemid 351201725)
62. Gonzalez, R.R. and Leavis, P.C. (2003). A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. Endocrine 21, 185-195. (Pubitemid 36936361)
63. Gonzalez, R.R., Cherfils, S., Escobar, M., Yoo, J.H., Carino, C., Styer, A.K., Sullivan, B.T., Sakamoto, H., Olawaiye, A., Serikawa, T., et al. (2006). Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J. Biol. Chem. 281, 26320-26328. (Pubitemid 44401840)
64. Gonzalez, R.R., Watters, A., Xu, Y., Singh, U.P., Mann, D.R., Rueda, B.R., and Penichet, M.L. (2009). Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res. 11, R36.
65. Gruen, M.L., Hao, M., Piston, D.W., and Hasty, A.H. (2007). Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am. J. Physiol. Cell Physiol. 293, C1481-C1488. (Pubitemid 350085627)
66. Guo, S. and Gonzalez-Perez, R.R. (2011). Notch, IL-1 and leptin crosstalk outcome (NILCO). Is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer. PLoS One 6, e21467.
67. Haglund, E., Sułkowska, J.I., He, Z., Feng, G-.S., Jennings, P., and Onuchic, J.N. (2012). The unique cysteine knot regulates the pleotropic hormone leptin. PLoS One 7, e45654.
68. Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D., Lallone, R.L., Burley, S.K., and Friedman, J.M. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
69. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E.B., Bendahman, N., and Hamers, R. (1993). Naturally occurring antibodies devoid of light chains. Nature 363, 446-448. (Pubitemid 23179389)
70. Haslam, D.W. and James, W.P.T. (2005). Obesity. Lancet 366, 1197-1209. (Pubitemid 41393598)
71. Hileman, S.M., Tornoe, J., Flier, J.S., and Bjorbaek, C. (2000). Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby Canine kidney cells. Endocrinology 141, 1955-1961. (Pubitemid 32274343)
72. El Homsi, M., Ducroc, R., Claustre, J., Jourdan, G., Gertler, A., Estienne, M., Bado, A., Scoazec, J.-Y., and Plaisancié P. (2007). Leptin modulates the expression of secreted and membraneassociated mucins in colonic epithelial cells by targeting, PKC, PI3K, and MAPK pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G365-G373. (Pubitemid 47105166)
73. Howard, J.K., Lord, G.M., Matarese, G., Vendetti, S., Ghatei, M.A., Ritter, M.A., Lechler, R.I., and Bloom, S.R. (1999). Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104, 1051-1059. (Pubitemid 29536315)
74. Hu, X., Juneja, S.C., Maihle, N.J., and Cleary, M.P. (2002). Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl. Cancer Inst. 94, 1704-11. (Pubitemid 35446839)
75. Iserentant, H., Peelman, F., Defeau, D., Vandekerckhove, J., Zabeau, L., and Tavernier, J. (2005). Mapping of the interface between leptin and the leptin receptor CRH2 domain. J. Cell Sci. 118, 2519-2527. (Pubitemid 40873091)
76. Iversen, P.O., Drevon, C.A., and Reseland, J.E. (2002). Prevention of leptin binding to its receptor suppresses rat leukemic cell growth by inhibiting angiogenesis. Blood 100, 4123-4128. (Pubitemid 35402054)
77. Jiang, L., Li, Z., and Rui, L. (2008). Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways. J. Biol. Chem. 283, 28066-28073.
78. Kastin, A.J., Pan, W., Maness, L.M., Koletsky, R.J., and Ernsberger, P. (1999). Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 20, 1449-1453. (Pubitemid 30069891)
79. Kellerer, M., Koch, M., Metzinger, E., Mushack, J., Capp, E., and Haing, H.U. (1997). Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40, 1358-1362. (Pubitemid 27469678)
80. Kloek, C., Haq, A.K., Dunn, S.L., Lavery, H.J., Banks, A.S., and Myers, M.G. (2002). Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277, 41547-41555. (Pubitemid 35257458)
81. Konstantinides, S., Schäfer, K., Koschnick, S., and Loskutoff, D.J. (2001). Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108, 1533-1540.
82. Kovalszky, I., Surmacz, E., Scolaro, L., Cassone, M., Ferla, R., Sztodola, A., Olah, J., Hatfield, M.P.D., Lovas, S., and Otvos, L. (2010). Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models. Diabetes Obes. Metab. 12, 393-402.
83. La Cava, A. and Matarese, G. (2004). The weight of leptin in immunity. Nat. Rev. Immunol 4, 371-379. (Pubitemid 38649279)
84. Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004). Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239-242. (Pubitemid 38886736)
85. Li, C. and Friedman, J.M. (1999). Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc. Natl. Acad. Sci. USA 96, 9677-9682. (Pubitemid 29398791)
86. Liao, L.M., Schwartz, K., Pollak, M., Graubard, B.I., Li, Z., Ruterbusch, J., Rothman, N., Davis, F., Wacholder, S., Colt, J., et al. (2013). Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Silver Spring). 21, 1478-1485.
87. Lord, G.M., Matarese, G., Howard, J.K., Baker, R.J., Bloom, S.R., and Lechler, R.I. (1998). Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901. (Pubitemid 28410912)
88. Lord, G.M., Matarese, G., Howard, J.K., Bloom, S.R., and Lechler, R.I. (2002). Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J. Leukoc. Biol. 72, 330-338.
89. Macia, L., Delacre, M., Abboud, G., Ouk, T.-S., Delanoye, A., Verwaerde, C., Saule, P., and Wolowczuk, I. (2006). Impairment of dendritic cell functionality and steady-state number in obese mice. J. Immunol. 177, 5997-6006. (Pubitemid 44628813)
90. Madej, T., Boguski, M.S., and Bryant, S.H. (1995). Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett. 373, 13-8.
91. Mancour, L., Daghestani, H., and Dutta, S. (2012). Ligand-induced architecture of the leptin receptor signaling complex. Mol. Cell 48, 1-7.
92. Mancuso, P., Canetti, C., Gottschalk, A., Tithof, P.K., and Peters- Golden, M. (2004). Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 287, L497-502.
93. Mandel, M. and Mahmoud, A. (1978). Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J. Immunol. 120, 1375-77. (Pubitemid 8334546)
94. Mansour, E., Pereira, F.G., Araujo, E.P., Amaral, M.E.C., Morari, J., Ferraroni, N.R., Ferreira, D.S., Lorand-Metze, I., Velloso, L.A., and Araújo, E.P. (2006). Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway. Endocrinology 147, 5470-5479.
95. Mark, A.L., Shaffer, R.A., Correia, M.L., Morgan, D.A., Sigmund, C.D., and Haynes, W.G. (1999). Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow bese mice. J. Hypertens. 17, 1949-1953. (Pubitemid 30345336)
96. Matarese, G., Di Giacomo, A., Sanna, V., Lord, G.M., Howard, J.K., Di Tuoro, A., Bloom, S.R., Lechler, R.I., Zappacosta, S., and Fontana, S. (2001). Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166, 5909-5916. (Pubitemid 32440714)
97. Matarese, G., La Cava, A., Sanna, V., Lord, G.M., Lechler, R.I., Fontana, S., and Zappacosta, S. (2002). Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol. 23, 182-187. (Pubitemid 34260933)
98. Matarese, G., Carrieri, P.B., La Cava, A., Perna, F., Sanna, V., De Rosa, V., Aufiero, D., Fontana, S., and Zappacosta, S. (2005). Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 102, 5150-5155.
99. Mattioli, B., Straface, E., Quaranta, M.G., Giordani, L., and Viora, M. (2005). Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J. Immunol. 174, 6820-6828. (Pubitemid 40705645)
100. Mattioli, B., Straface, E., Matarrese, P., Quaranta, M.G., Giordani, L., Malorni, W., and Viora, M. (2008). Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. FASEB J. 22, 2012-2022. (Pubitemid 351811477)
101. Mauro, L., Catalano, S., Bossi, G., Pellegrino, M., Barone, I., Morales, S., Giordano, C., Bartella, V., Casaburi, I., and Andó S. (2007). Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res. 67, 3412-3421. (Pubitemid 46724882)
102. McMurtry, V., Simeone, A.-M., Nieves-Alicea, R., and Tari, A.M. (2009). Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin. Exp. Metastasis 26, 197-204.
103. Mela, V., Díaz, F., Gertler, A., Solomon, G., Argente, J., Viveros, M.-P., and Chowen, J.A. (2012). Neonatal treatment with a pegylated leptin antagonist has a sexually dimorphic effect on hypothalamic trophic factors and neuropeptide levels. J. Neuroendocrinol. 24, 756-765.
104. Mercer, J.G., Hoggard, N., Williams, L.M., Lawrence, C.B., Hannah, L.T., and Trayhurn, P. (1996). Localization of leptin receptor mR, N.A., and the long form splice variant (Ob-Rb). In mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387, 113-116.
105. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Muller, C., Carling, D., and Kahn, B.B. (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343. (Pubitemid 34087557)
106. Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré P., Birnbaum, M.J., et al. (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574. (Pubitemid 38480541)
107. Miyamoto, L., Ebihara, K., Kusakabe, T., Aotani, D., Yamamoto- Kataoka, S., Sakai, T., Aizawa-Abe, M., Yamamoto, Y., Fujikura, J., Hayashi, T., et al. (2012). Leptin activates hepatic 5′-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J. Biol. Chem. 287, 40441-40447.
108. Munzberg, H., Flier, J.S., and Bjorbaek, C. (2004). Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145, 4880-4889. (Pubitemid 39551104)
109. Nair, P. (2005). Epidermal growth factor receptor family and its role in cancer progression. Curr. Sci. 88, 890-898. (Pubitemid 40793573)
110. Niv-Spector, L., Gonen-Berger, D., Gourdou, I., Biener, E., Gussakovsky, E.E., Benomar, Y., Ramanujan K, V., Taouis, M., Herman, B., Callebaut, I., et al. (2005a). Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem. J. 391, 221-230. (Pubitemid 41532418)
111. Niv-Spector, L., Raver, N., Friedman-Einat, M., Grosclaude, J., Gussakovsky, E.E., Livnah, O., and Gertler, A. (2005b). Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD). Subcloned from chicken leptin receptor. Biochem. J. 390, 475-484. (Pubitemid 41337109)
112. Niv-Spector, L., Shpilman, M., Boisclair, Y., and Gertler, A. (2012). Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist. Protein Expr. Purif. 81, 186-192.
113. Okumura, M., Yamamoto, M., Sakuma, H., Kojima, T., Maruyama, T., Jamali, M., Cooper, D.R., and Yasuda, K. (2002). Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim. Biophys. Acta 1592, 107-116.
114. Otvos, L., Terrasi, M., Cascio, S., Cassone, M., Abbadessa, G., De Pascali, F., Scolaro, L., Knappe, D., Stawikowski, M., Cudic, P., et al. (2008). Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim. Biophys. Acta 1783, 1745-1754.
115. Otvos, L., Kovalszky, I., Riolfi, M., Ferla, R., Olah, J., Sztodola, A., Nama, K., Molino, A., Piubello, Q., Wade, J.D., et al. (2011a). Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur. J. Cancer 47, 1578-1584.
116. Otvos, L., Kovalszky, I., Scolaro, L., Sztodola, A., Olah, J., Cassone, M., Knappe, D., Hoffmann, R., Lovas, S., Hatfield, M., et al. (2011b). Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation. Biopolymers 96, 117-125.
117. Otvos, L., Shao, W.-H., Vanniasinghe, A.S., Amon, M.A., Holub, M.C., Kovalszky, I., Wade, J.D., Doll, M., Cohen, P.L., Manolios, N., et al. (2011c). Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides 32, 1567-1574.
118. Ozata, M., Ozdemir, I.C., and Licinio, J. (1999). Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695. (Pubitemid 30645226)
119. Pais, R., Silaghi, H., Silaghi, A.-C., Rusu, M.-L., and Dumitrascu, D.-L. (2009). Metabolic syndrome and risk of subsequent colorectal cancer. World J. Gastroenterol. 15, 5141-5148.
120. Peelman, F., Van Beneden, K., Zabeau, L., Iserentant, H., Ulrichts, P., Defeau, D., Verhee, A., Catteeuw, D., Elewaut, D., and Tavernier, J. (2004). Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem. 279, 41038-41046. (Pubitemid 39287705)
121. Peelman, F., Iserentant, H., De Smet, A.S., Vandekerckhove, J., Zabeau, L., and Tavernier, J. (2006). Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin leptin receptor complex. J. Biol. Chem. 281, 15496-15504. (Pubitemid 43855142)
122. Perera, C.N., Chin, H.G., Duru, N., and Camarillo, I.G. (2008). Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. J. Endocrinol. 199, 221-233.
123. Purdham, D.M., Rajapurohitam, V., Zeidan, A., Huang, C., Gross, G.J., and Karmazyn, M. (2008). A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. Am. J. Physiol. Heart Circ. Physiol. 295, H441-H446.
124. Rahmouni, K., Sigmund, C.D., Haynes, W.G., and Mark, A.L. (2009). Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58, 536-542.
125. Rajapurohitam, V., Javadov, S., Purdham, D.M., Kirshenbaum, L.A., and Karmazyn, M. (2006). An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin I.I. and endothelin-1. J. Mol. Cell. Cardiol. 41, 265-274. (Pubitemid 44080214)
126. Ratke, J., Entschladen, F., Niggemann, B., Zänker, K.S., and Lang, K. (2010). Leptin stimulates the migration of colon carcinoma cells by multiple signaling pathways. Endocr. Relat. Cancer 17, 179-189.
127. Raver, N., Vardy, E., Livnah, O., Devos, R., and Gertler, A. (2002). Comparison of R128Q mutations in human, ovine, and chicken leptins. Gen. Comp. Endocrinol. 126, 52-58. (Pubitemid 34439160)
128. Ray, A. and Cleary, M.P. (2010). Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin. Ther. Targets 14, 443-451.
129. Rock, F.L., Altmann, S.W., van Heek, M., Kastelein, R.A., and Bazan, J.F. (1996). The leptin haemopoietic cytokine fold is stabilized by an intrachain disulfide bond. Horm. Metab. Res. 28, 649-652. (Pubitemid 27057909)
130. Rosenblum, C.I., Tota, M., Cully, D., Smith, T., Collum, R., Qureshi, S., Hess, J.F., Phillips, M.S., Hey, P.J., Vongs, A., et al. (1996). Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology 137, 5178-5181. (Pubitemid 26403367)
131. Rowlinson, S.W., Yoshizato, H., Barclay, J.L., Brooks, A.J., Behncken, S.N., Kerr, L.M., Millard, K., Palethorpe, K., Nielsen, K., Clyde-Smith, J., et al. (2008). An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nat. Cell Biol. 10, 740-747. (Pubitemid 351780137)
132. Samuel-Mendelsohn, S., Inbar, M., Weiss-Messer, E., Niv-Spector, L., Gertler, A., and Barkey, R.J. (2011). Leptin signaling and apoptotic effects in human prostate cancer cell lines. Prostate 71, 929-945.
133. Sanna, V., Di Giacomo, A., La Cava, A., Lechler, R.I., Fontana, S., Zappacosta, S., and Matarese, G. (2003). Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111, 241-250. (Pubitemid 36105923)
134. Saxena, N.K., Vertino, P.M., Anania, F.A., and Sharma, D. (2007). Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J. Biol. Chem. 282, 13316-13325. (Pubitemid 47100545)
135. Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P., and Baskin, D.G. (1996). Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98, 1101-1106. (Pubitemid 26299921)
136. Scolaro, L., Parrino, C., Coroniti, R., Otvos, L., and Surmacz, E. (2013). Exploring leptin antagonism in ophthalmic cell models. PLoS One 8, e76437.
137. Sen&tildrís, R., Garcia-Caballero, T., Casabiell, X., Gallego, R., Castro, R., Considine R.V., Dieguez, C., and Casanueva, F.F. (1997). Synthesis of leptin in human placenta. Endocrinology 138, 4501-4504. (Pubitemid 27408503)
138. Shapiro, N.I., Khankin E, V., Van Meurs, M., Shih, S.-C., Lu, S., Yano, M., Castro, P.R., Maratos-Flier, E., Parikh, S.M., Karumanchi, S.A., et al. (2010). Leptin exacerbates sepsismediated morbidity and mortality. J. Immunol. 185, 517-524.
139. Shpilman, M., Niv-Spector, L., Katz, M., Varol, C., Solomon, G., Ayalon-Soffer, M., Boder, E., Halpern, Z., Elinav, E., and Gertler, A. (2011). Development and characterization of high affinity leptins and leptin antagonists. J. Biol. Chem. 286, 4429-4442.
140. Siegmund, B., Lear-Kaul, K.C., Faggioni, R., and Fantuzzi, G. (2002). Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J. Immunol. 32, 552-560. (Pubitemid 34173346)
141. Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., García- Cardeñ, G., Papapetropoulos, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., and Polverini, P.J. (1998). Biological action of leptin as an angiogenic factor. Science 281, 1683-1686.
142. Simon, M., Stefan, N., Plückthun, A., and Zangemeister-Wittke, U. (2013). Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy. Expert Opin. Drug Deliv. 10, 451-468.
143. Singh, U.P., Singh, N.P., Guan, H., Busbee, B., Price, R.L., Taub, D.D., Mishra, M.K., Fayad, R., Nagarkatti, M., and Nagarkatti, P.S. (2013). Leptin antagonist ameliorates chronic colitis in IL-10-/- mice. Immunobiology 218, 1439-1451.
144. Smiechowska, J., Utech, A., Taffet, G., Hayes, T., Marcelli, M., and Garcia, J.M. (2010). Adipokines in patients with cancer anorexia and cachexia. J. Investig. Med. 58, 554-559.
145. Soma, D., Kitayama, J., Yamashita, H., Miyato, H., Ishikawa, M., and Nagawa, H. (2008). Leptin augments proliferation of breast cancer cells via transactivation of HER2. J. Surg. Res. 149, 9-14.
146. Tanaka, M., Suganami, T., Kim-Saijo, M., Toda, C., Tsuiji, M., Ochi, K., Kamei, Y., Minokoshi, Y., and Ogawa, Y. (2011). Role of central leptin signaling in the starvation-induced alteration of B-cell development. J. Neurosci. 31, 8373-8380.
147. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., et al. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271. (Pubitemid 26007816)
148. Tarzi, R.M., Cook, H.T., Jackson, I., Pusey, C.D., and Lord, G.M. (2004). Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am. J. Pathol. 164, 385-390. (Pubitemid 38364654)
149. Tian, Z., Sun, R., Wei, H., and Gao, B. (2002). Impaired natural killer (NK). Cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 298, 297-302. (Pubitemid 35333704)
150. Tisdale, M.J. (2002). Cachexia in cancer patients. Nat. Rev. Cancer 2, 862-871. (Pubitemid 37328904)
151. Uotani, S., Abe, T., and Yamaguchi, Y. (2006). Leptin activates AMP-activated protein kinase in hepatic cells via a JAK2-dependent pathway. Biochem. Biophys. Res. Commun. 351, 171-175. (Pubitemid 44635422)
152. Vaisse, C., Halaas, J.L., Horvath, C.M., Darnell, J.E., Stoffel, M., and Friedman, J.M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95-97. (Pubitemid 26301554)
153. Van der Linden, R., de Geus, B., Stok, W., Bos, W., van Wassenaar, D., Verrips, T., and Frenken, L. (2000). Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J. Immunol. Methods 240, 185-195. (Pubitemid 30347413)
154. Venken, K, Seeuws, S., Zabeau, L., Jacques, P., Decruy, T., Coudenys, J., Verheugen, E., Windels, F., Catteeuw, D., Drennan, M., et al. (2014). A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis. J. Hepatol. 60, 175-182.
155. Verploegen, S.A., Plaetinck, G., Devos, R., Van der Heyden, J., and Guisez, Y. (1997). A human leptin mutant induces weight gain in normal mice. FEBS Lett. 405, 237-240. (Pubitemid 27136517)
156. Wang, J., Liu, R., Hawkins, M., Barzilai, N., and Rossetti, L. (1998). A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393, 684-688. (Pubitemid 28289657)
157. Wauman, J. and Tavernier, J. (2011). Leptin receptor signaling: pathways to leptin resistance. Front. Biosci. 16, 2771-2793.
158. Wauman, J., De Smet, A.S., Catteeuw, D., Belsham, D., and Tavernier, J. (2008). Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways. Mol. Endocrinol. 22, 965-977. (Pubitemid 351482831)
159. Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904. (Pubitemid 28157668)
160. Xu, X., Su, S., Barnes, V.A., De Miguel, C., Pollock, J., Ownby, D., Shi, H., Zhu, H., Snieder, H., and Wang, X. (2013a). A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics 8, 522-533.
161. Xu, X., Zeng, H., Xiao, D., Zhou, H., and Liu, Z. (2013b). Genome wide association study of obesity. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 38, 95-100.
162. Yin, N., Wang, D., Zhang, H., Yi, X., Sun, X., Shi, B., Wu, H., Wu, G., Wang, X., and Shang, Y. (2004). Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res. 64, 5870-5875. (Pubitemid 39095588)
163. Yu, Y., Liu, Y., Shi, F.-D., Zou, H., Matarese, G., and La Cava, A. (2013). Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J. Immunol. 190, 3054-3058.
164. Zabeau, L., Defeau, D., Van der Heyden, J., Iserentant, H., Vandekerckhove, J., and Tavernier, J. (2004). Functional analysis of leptin receptor activation using a Janus kinase/ signal transducer and activator of transcription complementation assay. Mol. Endocrinol. 18, 150-161. (Pubitemid 38073161)
165. Zabeau, L., Defeau, D., Iserentant, H., Vandekerckhove, J., Peelman, F., and Tavernier, J. (2005). Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains. J. Biol. Chem. 280, 22632-22640. (Pubitemid 40853167)
166. Zabeau, L., Verhee, A., Catteeuw, D., Faes, L., Seeuws, S., Decruy, T., Elewaut, D., Peelman, F., and Tavernier, J. (2012). Selection of non-competitive leptin antagonists using a random nanobodybased approach. Biochem. J. 441, 425-434.
167. Zarkesh-Esfahani, H., Pockley, G., Metcalfe, R.A., Bidlingmaier, M., Wu, Z., Ajami, A., Weetman, A.P., Strasburger, C.J., and Ross, R.J. (2001). High-dose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 167, 4593-4599. (Pubitemid 32954339)
168. Zarkesh-Esfahani, H., Pockley, A.G., Wu, Z., Hellewell, P.G., Weetman, A.P., and Ross, R.J.M. (2004). Leptin indirectly activates human neutrophils via induction of TNF-α. J. Immunol. 172, 1809-1814. (Pubitemid 38116829)
169. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. (Pubitemid 24365442)
170. Zhang, F., Basinski, M.B., Beals, J.M., Briggs, S.L., Churgay, L.M., Clawson, D.K., DiMarchi, R.D., Furman, T.C., Hale, J.E., Hsiung, H.M., et al. (1997). Crystal structure of the obese protein leptin-E100. Nature 387, 206-209. (Pubitemid 27209439)
171. Zhang, E.E., Chapeau, E., Hagihara, K., and Feng, G.-S. (2004). Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. USA 101, 16064-16069. (Pubitemid 39507927)
172. Zhao, A.Z., Huan, J.-N., Gupta, S., Pal, R., and Sahu, A. (2002). A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat. Neurosci. 5, 727-728.
173. Zhao, Y., Sun, R., You, L., Gao, C., and Tian, Z. (2003). Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 300, 247-252. (Pubitemid 38375801)